Skip to main content

Ingenuity Extends License with GlaxoSmithKline

NEW YORK (GenomeWeb News) – Ingenuity Systems announced today that it has extended and expanded its licensing agreement with GlaxoSmithKline providing the drug giant with access to Ingenuity Pathways Analysis software.
 
The new pact enables GSK to provide enterprise-wide IPA access to researchers assessing signaling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets. GSK also will use Ingenuity’s content and proprietary algorithms, the Redwood City, Calif.-based bioinformatics firm said in a statement.
 
Financial terms of the agreement were not disclosed.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.